Story thread · 2 reports / 2 sources

Electra's $350M IPO will help it become a commercial biotech

endpts.com · 20hShare

Electra Therapeutics became the 21st biotech of 2026 to go through with an IPO after pricing its $350 million Nasdaq debut on Thursday evening. The Bay Area biotech will use the ...

First report: 8 biotech IPO prospects testing investor appetite — finance.yahoo.com, 1d